Four Glucose Patterns Identified in Older Adults With Diabetes
Continuous glucose monitoring data from 2,491 adults aged 60 and older reveals distinct phenotypes linked to cardiovascular-kidney-metabolic risk.
Updated on Nov. 21, 2026 in Diabetes

Researchers identified four distinct glycaemic phenotypes among older adults with Type 2 diabetes using continuous glucose monitoring. The high glucose exposure and low variability phenotype showed the strongest association with advanced cardiovascular-kidney-metabolic (CKM) syndrome.
Why it matters
The findings suggest that glucose patterns captured by continuous monitoring may reveal risk beyond what standard HbA1c measurements show. Prospective studies are still needed to determine whether these phenotypes can predict CKM progression and cardiorenal outcomes.
The study used seven days of blinded continuous glucose monitoring in 2,491 adults aged 60 and older, with 65.0% overall showing advanced CKM syndrome. Whether these phenotypes forecast disease progression has not yet been established.
The details
Participants were divided into four groups based on whether their time above range (TAR) and mean amplitude of glycaemic excursions (MAGE) fell above or below the study population's median values of 27.0% and 5.3 mmol/L. The high-TAR, low-MAGE group had the highest fasting plasma glucose and triglyceride levels and the lowest insulin sensitivity of the four groups, while participants with both high TAR and high MAGE had the highest median HbA1c.
Timeline
Participants maintained stable glucose-lowering regimens for three months before enrollment.
Participants completed seven days of blinded continuous glucose monitoring.
Findings were published on emjreviews.com on November 21, 2026.
Health Landscape
The study applies the American Heart Association's criteria for cardiovascular-kidney-metabolic syndrome to continuous glucose monitoring data, extending that framework beyond single-point HbA1c readings. It adds to a growing body of work asking whether glycaemic variability, not just average glucose, carries clinical weight.
For older adults with Type 2 diabetes, the study suggests that tracking glucose swings over time, not just average levels, may matter for heart and kidney health. Patients should discuss continuous monitoring options with their clinicians, though the findings are not yet a basis for changing treatment.
The takeaway
Average blood sugar alone may not capture everything; glucose variability in older adults with Type 2 diabetes appears to carry its own cardiometabolic signal worth watching.
Further reading
Explore more on Diabetes research and management.
Source note: This article includes information reported by European Medical Journal.



